Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Piramal Enterprises to demerge healthcare, financial services

      Piramal Enterprises to demerge healthcare, financial services

      supriya kashyap kashyap31 Jan 2017 10:28 AM IST
      Mumbai : The Ajay Piramal-led Piramal Enterprises will demerge its healthcare and financial services businesses soon, a top company official...
      Piramal to acquire drugs from UKs Mallinckrodt for Rs 1,162 crore

      Piramal to acquire drugs from UKs Mallinckrodt for Rs 1,162 crore

      supriya kashyap kashyap31 Jan 2017 10:27 AM IST
      New Delhi : Piramal Enterprises said it will acquire a portfolio of intrathecal spasticity and pain management drugs from UK-based Mallinckrodt for...
      Suven Life gets patent for anti neuro degenerative drug

      Suven Life gets patent for anti neuro degenerative drug

      supriya kashyap kashyap31 Jan 2017 10:25 AM IST
      New Delhi : Drug firm Suven Life Sciences has been granted a patent by the US for a drug to cure neuro-degenerative diseases.In a BSE filing, Suven...
      Tata Chemicals proposes Rs 250 cr investment in nutritional products

      Tata Chemicals proposes Rs 250 cr investment in nutritional products

      supriya kashyap kashyap31 Jan 2017 10:24 AM IST
      New Delhi : Tata Chemicals plans to invest Rs 200-250 crore for the development of nutritional products in Andhra Pradesh.The company signed a...
      Drugmaker Novo Nordisk bets $145 million on post-Brexit UK science

      Drugmaker Novo Nordisk bets $145 million on post-Brexit UK science

      supriya kashyap kashyap31 Jan 2017 10:23 AM IST
      London : Novo Nordisk, the world's top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain,...
      HC allows Indian firm to export drug in which Bayer has patent

      HC allows Indian firm to export drug in which Bayer has patent

      supriya kashyap kashyap30 Jan 2017 11:31 AM IST
      New Delhi : In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an Indian drug company from...
      Roche cancer drug taking bite out of Bristols Opdivo

      Roche cancer drug taking bite out of Bristol's Opdivo

      supriya kashyap kashyap30 Jan 2017 11:29 AM IST
      Roche's cancer drug Tecentriq hit the market months behind immuno-oncology (I/O) medicines from Merck and Bristol-Myers Squibb Co but the Swiss...
      Donald Trumps policy not to hit Indian IT, pharma firms: Ananth Kumar

      Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar

      supriya kashyap kashyap30 Jan 2017 11:29 AM IST
      Bengaluru : Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the US is expected to continue "the...
      Dutch commit $10 million to replace lost US abortion funding

      Dutch commit $10 million to replace lost US abortion funding

      supriya kashyap kashyap30 Jan 2017 11:28 AM IST
      The Netherlands has committed $10 million for an initiative to replace funding for abortion services in developing countries that will be lost due to...
      Guest Blog: Budget expectations with CEO Fortis Healthcare Ltd

      Guest Blog: Budget expectations with CEO Fortis Healthcare Ltd

      supriya kashyap kashyap29 Jan 2017 1:36 PM IST
      As the Nation looks forward to the Union Budget 2017, there is a lot of hope and anticipation especially for healthcare, which needs to be viewed as a...
      Novartis launches $5 billion share buyback, mulls Alcon spin-off

      Novartis launches $5 billion share buyback, mulls Alcon spin-off

      supriya kashyap kashyap28 Jan 2017 12:26 PM IST
      Switzerland : Swiss drugmaker Novartis (NOVN.S) said it will buy back up to $5 billion worth of shares over the next 12 months and may spin off the...
      FDA confirms elevated levels of belladonna in certain homeopathic teething products

      FDA confirms elevated levels of belladonna in certain homeopathic teething products

      supriya kashyap kashyap28 Jan 2017 12:26 PM IST
      The U.S. Food and Drug Administration announced that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok